|

SHR-1316、Paclitaxel (Albumin Bound)、Carboplatin Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • Jiangsu HengRui Medicine Co., Ltd.1

Indications

  • Lung Cancer1
  • Non Small Cell Lung Cancer1
  • Cancer1

Other1 trial

A Trial of SHR-1316/Placebo in Combination With Chemotherapy in Patients With Resectable NSCLC
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.